These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


469 related items for PubMed ID: 30702012

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Adalimumab in treatment-resistant hidradenitis suppurativa following recurrence after extensive affected area excision: a review of biologics therapy.
    Samycia M, Brassard A.
    J Cutan Med Surg; 2013 Oct; 17 Suppl 1():S23-32. PubMed ID: 24144253
    [Abstract] [Full Text] [Related]

  • 23. New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.
    Molinelli E, Gioacchini H, Sapigni C, Diotallevi F, Brisigotti V, Rizzetto G, Offidani A, Simonetti O.
    Int J Mol Sci; 2023 May 08; 24(9):. PubMed ID: 37176138
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review.
    Sachdeva M, Kim P, Mufti A, Maliyar K, Sibbald C, Alavi A.
    J Cutan Med Surg; 2022 May 08; 26(2):176-180. PubMed ID: 34587768
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Secukinumab in the treatment of hidradenitis suppurativa.
    Snyder CL, Gibson RS, Porter ML, Kimball AB.
    Immunotherapy; 2023 Dec 08; 15(17):1449-1457. PubMed ID: 37840286
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa.
    Molinelli E, Sapigni C, Campanati A, Brisigotti V, Offidani A.
    Expert Opin Drug Metab Toxicol; 2020 Nov 08; 16(11):1019-1037. PubMed ID: 32896186
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. New perspectives on the treatment of hidradenitis suppurativa.
    Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, Puig L.
    Ther Adv Chronic Dis; 2021 Nov 08; 12():20406223211055920. PubMed ID: 34840709
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease.
    Nomura T.
    Front Immunol; 2020 Nov 08; 11():847. PubMed ID: 32508815
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.